慢性呼吸系统疾病是COVID-19住院患者严重结局的预测因素:一项全国性研究
这项法国全国性回顾性队列研究比较了COVID-19住院患者(89 530例)与流感住院患者(45 819例)中慢性呼吸系统疾病(CRD)的分布及结局。COVID-19患者中CRD比例(16.03%)显著低于流感患者,但合并CRD的COVID-19患者发生呼吸机相关肺炎和肺栓塞更多,需重症监护更频繁,死亡率更高(哮喘除外)。
要点
- 合并CRD的COVID-19住院患者较无CRD的COVID-19患者及流感患者更易出现严重结局和高死亡率。
- COVID-19住院患者中CRD总体比例低于流感住院患者,但肺癌、睡眠呼吸暂停、肺气肿和间质性肺疾病比例相对较高。
- 哮喘患者死亡率未显著升高,但其他CRD(如COPD、慢性呼吸衰竭)患者死亡率更高。
核心结论
- 有呼吸系统疾病史的患者因COVID-19住院的可能性总体低于流感,但一旦住院,发生重症COVID-19和死亡的风险高于流感患者及无呼吸疾病史的COVID-19患者。
研究设计与样本
- 法国全国性回顾性队列研究,纳入2020年3-4月因COVID-19住院的患者89 530例和2018-2019年流感季因流感住院的患者45 819例,比较不同呼吸疾病史和病毒类型下的肺部并发症、重症监护需求和院内死亡率。
主要发现
- COVID-19住院患者中16.03%至少有一种CRD,显著低于流感住院患者中的比例。
- 慢性呼吸衰竭、COPD、哮喘、囊性纤维化和肺动脉高压患者在COVID-19中比例偏低,而肺癌、睡眠呼吸暂停、肺气肿和间质性肺疾病患者比例相对较高。
- 合并CRD的COVID-19患者发生呼吸机相关肺炎和肺栓塞显著多于流感患者。
- 合并CRD的COVID-19患者需要重症监护更频繁,死亡率更高(哮喘除外), compared with COVID-19 patients without CRDs or influenza patients.
临床怎么用
- 对于有慢性呼吸系统疾病史的COVID-19住院患者,应警惕呼吸机相关肺炎、肺栓塞等并发症,并加强重症监护资源准备。
- 哮喘患者的管理可参考一般COVID-19原则,但其他CRD(如COPD、慢性呼吸衰竭)患者需更积极监测和干预以降低死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Influenza epidemics were initially considered to be a suitable model for the COVID-19 epidemic, but there is a lack of data concerning patients with chronic respiratory diseases (CRDs), who were supposed to be at risk of severe forms of COVID-19. METHODS: This nationwide retrospective cohort study describes patients with prior lung disease hospitalised for COVID-19 (March-April 2020) or influenza (2018-2019 influenza outbreak). We compared the resulting pulmonary complications, need for intensive care and in-hospital mortality depending on respiratory history and virus. RESULTS: In the 89 530 COVID-19 cases, 16.03% had at least one CRD, which was significantly less frequently than in the 45 819 seasonal influenza patients. Patients suffering from chronic respiratory failure, chronic obstructive pulmonary disease, asthma, cystic fibrosis and pulmonary hypertension were under-represented, contrary to those with lung cancer, sleep apnoea, emphysema and interstitial lung diseases. COVID-19 patients with CRDs developed significantly more ventilator-associated pneumonia and pulmonary embolism than influenza patients. They needed intensive care significantly more often and had a higher mortality rate (except for asthma) when compared with patients with COVID-19 but without CRDs or patients with influenza. CONCLUSIONS: Patients with prior respiratory diseases were globally less likely to be hospitalised for COVID-19 than for influenza, but were at higher risk of developing severe COVID-19 and had a higher mortality rate compared with influenza patients and patients without a history of respiratory illness.
引用
- Beltramo G, Cottenet J, Mariet AS, et al. Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study. Eur Respir J. 2021. PMID: 34016619. doi:10.1183/13993003.04474-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。